10-30623101-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_183058.3(LYZL2):c.298+3004C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.856 in 152,210 control chromosomes in the GnomAD database, including 56,287 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.86 ( 56287 hom., cov: 32)
Consequence
LYZL2
NM_183058.3 intron
NM_183058.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.229
Publications
7 publications found
Genes affected
LYZL2 (HGNC:29613): (lysozyme like 2) Lysozymes (see LYZ; MIM 153450), especially C-type lysozymes, are well-recognized bacteriolytic factors widely distributed in the animal kingdom and play a mainly protective role in host defense. LYZL2 is a member of a family of lysozyme-like genes (Zhang et al., 2005 [PubMed 16014814]).[supplied by OMIM, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.905 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LYZL2 | NM_183058.3 | c.298+3004C>A | intron_variant | Intron 3 of 4 | ENST00000647634.2 | NP_898881.3 | ||
| LYZL2 | XM_011519306.3 | c.436+3004C>A | intron_variant | Intron 3 of 3 | XP_011517608.1 | |||
| LYZL2 | XR_930469.3 | n.484+3004C>A | intron_variant | Intron 3 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.856 AC: 130180AN: 152092Hom.: 56250 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
130180
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.856 AC: 130267AN: 152210Hom.: 56287 Cov.: 32 AF XY: 0.853 AC XY: 63502AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
130267
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
63502
AN XY:
74414
show subpopulations
African (AFR)
AF:
AC:
37920
AN:
41534
American (AMR)
AF:
AC:
11615
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2941
AN:
3472
East Asian (EAS)
AF:
AC:
2681
AN:
5168
South Asian (SAS)
AF:
AC:
3612
AN:
4820
European-Finnish (FIN)
AF:
AC:
9741
AN:
10596
Middle Eastern (MID)
AF:
AC:
271
AN:
294
European-Non Finnish (NFE)
AF:
AC:
58923
AN:
68014
Other (OTH)
AF:
AC:
1810
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
926
1852
2777
3703
4629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2347
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.